{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:28:02Z","timestamp":1794432482228,"version":"4.9.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002426","name":"Fondazione Telethon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002426","id-type":"DOI","asserted-by":"publisher"}]},{"name":"nChroma Bio"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-72846-2","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:06:53Z","timestamp":1778490413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Simultaneous orthogonal cell engineering by a single CRISPR-Cas9 polyfunctional editor"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0398-8386","authenticated-orcid":false,"given":"Deborah","family":"Cipria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Baccega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8094-8646","authenticated-orcid":false,"given":"Miriana","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3839-3383","authenticated-orcid":false,"given":"Piergiuseppe","family":"Quarato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2207-2041","authenticated-orcid":false,"given":"Alice","family":"Reschigna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9688-7336","authenticated-orcid":false,"given":"Rita","family":"El Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1948-0772","authenticated-orcid":false,"given":"Martino Alfredo","family":"Cappelluti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-1890","authenticated-orcid":false,"given":"Sandra","family":"Ammann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria Mollica","family":"Poeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3109-4073","authenticated-orcid":false,"given":"Matteo","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0512-1376","authenticated-orcid":false,"given":"Sara","family":"Valsoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Merelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7757-4630","authenticated-orcid":false,"given":"Toni","family":"Cathomen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4500-9060","authenticated-orcid":false,"given":"Monica","family":"Casucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8262-042X","authenticated-orcid":false,"given":"Angelo","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"72846_CR1","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1126\/science.aat5011","volume":"361","author":"GJ Knott","year":"2018","unstructured":"Knott, G. J. & Doudna, J. A. CRISPR-Cas guides the future of genetic engineering. Science 361, 866\u2013869 (2018).","journal-title":"Science"},{"key":"72846_CR2","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816\u2013821 (2012).","journal-title":"Science"},{"key":"72846_CR3","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823\u2013826 (2013).","journal-title":"Science"},{"key":"72846_CR4","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nature21405","volume":"543","author":"J Eyquem","year":"2017","unstructured":"Eyquem, J. et al. Targeting a CAR to the TRAC locus with CRISPR\/Cas9 enhances tumour rejection. Nature 543, 113\u2013117 (2017).","journal-title":"Nature"},{"key":"72846_CR5","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41586-018-0326-5","volume":"559","author":"TL Roth","year":"2018","unstructured":"Roth, T. L. et al. Reprogramming human T cell function and specificity with non-viral genome targeting. Nature 559, 405\u2013409 (2018).","journal-title":"Nature"},{"key":"72846_CR6","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/s41551-019-0409-0","volume":"3","author":"K Schober","year":"2019","unstructured":"Schober, K. et al. Orthotopic replacement of T-cell receptor \u03b1- and \u03b2-chains with preservation of near-physiological T-cell function. Nat. Biomed. Eng. 3, 974\u2013984 (2019).","journal-title":"Nat. Biomed. Eng."},{"key":"72846_CR7","doi-asserted-by":"publisher","first-page":"eabg8027","DOI":"10.1126\/scitranslmed.abg8027","volume":"14","author":"E Ruggiero","year":"2022","unstructured":"Ruggiero, E. et al. CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function. Sci. Transl. Med. 14, eabg8027 (2022).","journal-title":"Sci. Transl. Med."},{"key":"72846_CR8","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/hum.2023.128","volume":"34","author":"C Bonini","year":"2023","unstructured":"Bonini, C. et al. Genome editing in engineered T cells for cancer immunotherapy. Hum. Gene Ther. 34, 853\u2013869 (2023).","journal-title":"Hum. Gene Ther."},{"key":"72846_CR9","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.4192","volume":"36","author":"M Kosicki","year":"2018","unstructured":"Kosicki, M., Tomberg, K. & Bradley, A. Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat. Biotechnol. 36, 765\u2013771 (2018).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR10","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.stem.2021.02.002","volume":"28","author":"G Turchiano","year":"2021","unstructured":"Turchiano, G. et al. Quantitative evaluation of chromosomal rearrangements in gene-edited human stem cells by CAST-Seq. Cell Stem Cell 28, 1136\u20131147.e5 (2021).","journal-title":"Cell Stem Cell"},{"key":"72846_CR11","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/s41587-022-01377-0","volume":"40","author":"AD Nahmad","year":"2022","unstructured":"Nahmad, A. D. et al. Frequent aneuploidy in primary human T cells after CRISPR-Cas9 cleavage. Nat. Biotechnol. 40, 1807\u20131813 (2022).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR12","unstructured":"Stadtmauer, E. A. et al. CRISPR-engineered T cells in patients with refractory cancer. Science 367, eaba7365 (2020)."},{"key":"72846_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1089\/crispr.2019.0074","volume":"3","author":"A Bothmer","year":"2020","unstructured":"Bothmer, A. et al. Detection and modulation of DNA translocations during multi-gene genome editing in T. Cells. CRISPR J. 3, 177\u2013187 (2020).","journal-title":"Cells. CRISPR J."},{"key":"72846_CR14","doi-asserted-by":"publisher","first-page":"eabq3010","DOI":"10.1126\/scitranslmed.abq3010","volume":"14","author":"G Ottaviano","year":"2022","unstructured":"Ottaviano, G. et al. Phase 1 clinical trial of CRISPR-engineered CAR19 universal T cells for treatment of children with refractory B cell leukemia. Sci. Transl. Med. 14, eabq3010 (2022).","journal-title":"Sci. Transl. Med."},{"key":"72846_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28900-w","volume":"13","author":"J Yin","year":"2022","unstructured":"Yin, J. et al. Cas9 exo-endonuclease eliminates chromosomal translocations during genome editing. Nat. Commun. 13, 1204 (2022).","journal-title":"Nat. Commun."},{"key":"72846_CR16","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1182\/blood-2016-10-706465","volume":"129","author":"T Girardi","year":"2017","unstructured":"Girardi, T., Vicente, C., Cools, J. & De Keersmaecker, K. The genetics and molecular biology of T-ALL. Blood 129, 1113\u20131123 (2017).","journal-title":"Blood"},{"key":"72846_CR17","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41573-020-0084-6","volume":"19","author":"EM Porto","year":"2020","unstructured":"Porto, E. M., Komor, A. C., Slaymaker, I. M. & Yeo, G. W. Base editing: advances and therapeutic opportunities. Nat. Rev. Drug Discov. 19, 839\u2013859 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"72846_CR18","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa2300709","volume":"389","author":"R Chiesa","year":"2023","unstructured":"Chiesa, R. et al. Base-edited CAR7 T cells for relapsed T-cell acute lymphoblastic leukemia. N. Engl. J. Med. 389, 899\u2013910 (2023).","journal-title":"N. Engl. J. Med."},{"key":"72846_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1056\/NEJMoa2505478","volume":"394","author":"R Chiesa","year":"2026","unstructured":"Chiesa, R. et al. Universal base-edited CAR7 T cells for T-cell acute lymphoblastic leukemia. N. Engl. J. Med. 394, 152\u2013165 (2026).","journal-title":"N. Engl. J. Med."},{"key":"72846_CR20","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41556-023-01342-2","volume":"26","author":"ME Huang","year":"2024","unstructured":"Huang, M. E. et al. C-to-G editing generates double-strand breaks causing deletion, transversion and translocation. Nat. Cell Biol. 26, 294\u2013304 (2024).","journal-title":"Nat. Cell Biol."},{"key":"72846_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-024-03434-0","volume":"25","author":"L Wu","year":"2024","unstructured":"Wu, L. et al. Adenine base editors induce off-target structure variations in mouse embryos and primary human T cells. Genome Biol 25, 291 (2024).","journal-title":"Genome Biol"},{"key":"72846_CR22","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/s41587-023-01915-4","volume":"42","author":"M Fiumara","year":"2024","unstructured":"Fiumara, M. et al. Genotoxic effects of base and prime editing in human hematopoietic stem cells. Nat. Biotechnol. 42, 877\u2013891 (2024).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cell.2016.09.006","volume":"167","author":"A Amabile","year":"2016","unstructured":"Amabile, A. et al. Inheritable silencing of endogenous genes by hit-and-run targeted epigenetic editing. Cell 167, 219\u2013232.e14 (2016).","journal-title":"Cell"},{"key":"72846_CR24","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1016\/j.cell.2021.03.025","volume":"184","author":"JK N\u00fa\u00f1ez","year":"2021","unstructured":"N\u00fa\u00f1ez, J. K. et al. Genome-wide programmable transcriptional memory by CRISPR-based epigenome editing. Cell 184, 2503\u20132519.e17 (2021).","journal-title":"Cell"},{"key":"72846_CR25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41586-024-07087-8","volume":"627","author":"MA Cappelluti","year":"2024","unstructured":"Cappelluti, M. A. et al. Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature 627, 416\u2013423 (2024).","journal-title":"Nature"},{"key":"72846_CR26","doi-asserted-by":"publisher","unstructured":"Tremblay, F. et al. A potent epigenetic editor targeting human PCSK9 for durable reduction of low-density lipoprotein cholesterol levels. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-025-03508-x (2025).","DOI":"10.1038\/s41591-025-03508-x"},{"key":"72846_CR27","doi-asserted-by":"publisher","unstructured":"Mao, S. et al. Design of optimized epigenetic regulators for durable gene silencing with application to PCSK9 in nonhuman primates. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02838-y (2025).","DOI":"10.1038\/s41587-025-02838-y"},{"key":"72846_CR28","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nbt.2808","volume":"32","author":"Y Fu","year":"2014","unstructured":"Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M. & Joung, J. K. Improving CRISPR-Cas nuclease specificity using truncated guide RNAs. Nat. Biotechnol. 32, 279\u2013284 (2014).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/nbt.3390","volume":"33","author":"JE Dahlman","year":"2015","unstructured":"Dahlman, J. E. et al. Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease. Nat. Biotechnol. 33, 1159\u20131161 (2015).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR30","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/nmeth.3580","volume":"12","author":"S Kiani","year":"2015","unstructured":"Kiani, S. et al. Cas9 gRNA engineering for genome editing, activation and repression. Nat. Methods 12, 1051\u20131054 (2015).","journal-title":"Nat. Methods"},{"key":"72846_CR31","doi-asserted-by":"publisher","first-page":"4171","DOI":"10.1093\/nar\/gkab174","volume":"49","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. MiniCAFE, a CRISPR\/Cas9-based compact and potent transcriptional activator, elicits gene expression in vivo. Nucleic Acids Res 49, 4171\u20134185 (2021).","journal-title":"Nucleic Acids Res"},{"key":"72846_CR32","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nmeth.1674","volume":"8","author":"A Lombardo","year":"2011","unstructured":"Lombardo, A. et al. Site-specific integration and tailoring of cassette design for sustainable gene transfer. Nat. Methods 8, 861\u2013869 (2011).","journal-title":"Nat. Methods"},{"key":"72846_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50012-w","volume":"15","author":"Z Yi","year":"2024","unstructured":"Yi, Z. et al. Programmable DNA pyrimidine base editing via engineered uracil-DNA glycosylase. Nat. Commun. 15, 6397 (2024).","journal-title":"Nat. Commun."},{"key":"72846_CR34","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41592-020-0966-x","volume":"17","author":"N Alerasool","year":"2020","unstructured":"Alerasool, N., Segal, D., Lee, H. & Taipale, M. An efficient KRAB domain for CRISPRi applications in human cells. Nat. Methods 17, 1093\u20131096 (2020).","journal-title":"Nat. Methods"},{"key":"72846_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02856-w","author":"L Goudy","year":"2025","unstructured":"Goudy, L. et al. Integrated epigenetic and genetic programming of primary human T cells. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-025-02856-w (2025).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63167-x","volume":"16","author":"D Xu","year":"2025","unstructured":"Xu, D. et al. Programmable epigenome editing by transient delivery of CRISPR epigenome editor ribonucleoproteins. Nat. Commun 16, 7948 (2025).","journal-title":"Nat. Commun"},{"key":"72846_CR37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1182\/blood.2022019333","volume":"142","author":"V Vavassori","year":"2023","unstructured":"Vavassori, V. et al. Lipid nanoparticles allow efficient and harmless ex vivo gene editing of human hematopoietic cells. Blood 142, 812\u2013826 (2023).","journal-title":"Blood"},{"key":"72846_CR38","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nm.2700","volume":"18","author":"E Provasi","year":"2012","unstructured":"Provasi, E. et al. Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer. Nat. Med. 18, 807\u2013815 (2012).","journal-title":"Nat. Med."},{"key":"72846_CR39","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1182\/blood-2016-08-732636","volume":"130","author":"S Mastaglio","year":"2017","unstructured":"Mastaglio, S. et al. NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease. Blood 130, 606\u2013618 (2017).","journal-title":"Blood"},{"key":"72846_CR40","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1158\/2326-6066.CIR-18-0508","volume":"8","author":"Y Kagoya","year":"2020","unstructured":"Kagoya, Y. et al. Genetic ablation of HLA Class I, Class II, and the T-cell receptor enables allogeneic T cells to be used for adoptive T-cell therapy. Cancer Immunol. Res. 8, 926\u2013936 (2020).","journal-title":"Cancer Immunol. Res."},{"key":"72846_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-3338-9_10","volume":"1393","author":"L Falcone","year":"2016","unstructured":"Falcone, L. & Casucci, M. Exploiting secreted luciferases to monitor tumor progression in vivo. Methods Mol. Biol. 1393, 105\u2013111 (2016).","journal-title":"Methods Mol. Biol."},{"key":"72846_CR42","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41586-018-0178-z","volume":"558","author":"JA Fraietta","year":"2018","unstructured":"Fraietta, J. A. et al. Disruption of TET2 promotes the therapeutic efficacy of CD19-targeted T cells. Nature 558, 307\u2013312 (2018).","journal-title":"Nature"},{"key":"72846_CR43","doi-asserted-by":"publisher","first-page":"eadp9371","DOI":"10.1126\/sciadv.adp9371","volume":"10","author":"AJ Dimitri","year":"2024","unstructured":"Dimitri, A. J. et al. TET2 regulates early and late transitions in exhausted CD8\u2009+\u2009T cell differentiation and limits CAR T cell function. Sci. Adv. 10, eadp9371 (2024).","journal-title":"Sci. Adv."},{"key":"72846_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30896-2","volume":"13","author":"S Jo","year":"2022","unstructured":"Jo, S. et al. Endowing universal CAR T-cell with immune-evasive properties using TALEN gene editing. Nat. Commun. 13, 3453 (2022).","journal-title":"Nat. Commun."},{"key":"72846_CR45","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse, G. G. et al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat. Biotechnol. 35, 765\u2013772 (2017).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR46","doi-asserted-by":"publisher","first-page":"111423","DOI":"10.1016\/j.celrep.2022.111423","volume":"40","author":"R Chimienti","year":"2022","unstructured":"Chimienti, R. et al. Engineering of immune checkpoints B7-H3 and CD155 enhances immune compatibility of MHC-I-\/- iPSCs for \u03b2 cell replacement. Cell Rep. 40, 111423 (2022).","journal-title":"Cell Rep."},{"key":"72846_CR47","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/j.ymthe.2018.05.003","volume":"26","author":"CC Kloss","year":"2018","unstructured":"Kloss, C. C. et al. Dominant-negative TGF-\u03b2 receptor enhances PSMA-targeted human CAR T cell proliferation and augments prostate cancer eradication. Mol. Ther. 26, 1855\u20131866 (2018).","journal-title":"Mol. Ther."},{"key":"72846_CR48","doi-asserted-by":"crossref","unstructured":"Tang, N. et al. TGF-\u03b2 inhibition via CRISPR promotes the long-term efficacy of CAR T cells against solid tumors. JCI Insight 5, e133977 (2020).","DOI":"10.1172\/jci.insight.133977"},{"key":"72846_CR49","doi-asserted-by":"crossref","unstructured":"Fix, S. M. et al. CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-\u03b2 signaling. J. Immunother. Cancer 10, e003750 (2022).","DOI":"10.1136\/jitc-2021-003750"},{"key":"72846_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-66737-1","volume":"16","author":"R Murray","year":"2025","unstructured":"Murray, R. et al. Multiplex gene-editing strategy to engineer allogeneic EGFR-targeting CAR T-cells with improved efficacy against solid tumors. Nat. Commun. 16, 11593 (2025).","journal-title":"Nat. Commun."},{"key":"72846_CR51","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-025-03851-9","volume":"26","author":"M Wang","year":"2025","unstructured":"Wang, M., Zhang, Y., Bi, C. & Li, M. CRISPR-Cas9-induced double-strand breaks disrupt maintenance of epigenetic information. Genome Biol. 26, 411 (2025).","journal-title":"Genome Biol."},{"key":"72846_CR52","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.stem.2025.07.009","volume":"32","author":"X Hu","year":"2025","unstructured":"Hu, X. et al. Hypoimmune CD19 CAR T cells evade allorejection in patients with cancer and autoimmune disease. Cell Stem Cell 32, 1356\u20131368.e4 (2025).","journal-title":"Cell Stem Cell"},{"key":"72846_CR53","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.stem.2025.03.004","volume":"32","author":"T Deuse","year":"2025","unstructured":"Deuse, T. & Schrepfer, S. Progress and challenges in developing allogeneic cell therapies. Cell Stem Cell 32, 513\u2013528 (2025).","journal-title":"Cell Stem Cell"},{"key":"72846_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-023-02928-7","volume":"24","author":"V Glaser","year":"2023","unstructured":"Glaser, V. et al. Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells. Genome Biol. 24, 89 (2023).","journal-title":"Genome Biol."},{"key":"72846_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41587-022-01418-8","volume":"41","author":"BR Shy","year":"2023","unstructured":"Shy, B. R. et al. High-yield genome engineering in primary cells using a hybrid ssDNA repair template and small-molecule cocktails. Nat. Biotechnol. 41, 521\u2013531 (2023).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR56","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.cell.2020.11.024","volume":"183","author":"J Tycko","year":"2020","unstructured":"Tycko, J. et al. High-throughput discovery and characterization of human transcriptional effectors. Cell 183, 2020\u20132035.e16 (2020).","journal-title":"Cell"},{"key":"72846_CR57","doi-asserted-by":"publisher","unstructured":"Tycko, J. et al. Development of compact transcriptional effectors using high-throughput measurements in diverse contexts. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-024-02442-6 (2024).","DOI":"10.1038\/s41587-024-02442-6"},{"key":"72846_CR58","doi-asserted-by":"publisher","first-page":"102618","DOI":"10.1016\/j.omtn.2025.102618","volume":"36","author":"MS Roman Azcona","year":"2025","unstructured":"Roman Azcona, M. S. et al. Sustained and specific multiplexed immune checkpoint modulation in CAR T cells induced by targeted epigenome editing. Mol. Ther. Nucleic Acids 36, 102618 (2025).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"72846_CR59","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature16526","volume":"529","author":"BP Kleinstiver","year":"2016","unstructured":"Kleinstiver, B. P. et al. High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects. Nature 529, 490\u2013495 (2016).","journal-title":"Nature"},{"key":"72846_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40344-4","volume":"14","author":"S Wimberger","year":"2023","unstructured":"Wimberger, S. et al. Simultaneous inhibition of DNA-PK and Pol\u03f4 improves integration efficiency and precision of genome editing. Nat. Commun. 14, 4761 (2023).","journal-title":"Nat. Commun."},{"key":"72846_CR61","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154, 1380\u20131389 (2013).","journal-title":"Cell"},{"key":"72846_CR62","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1016\/j.celrep.2018.02.014","volume":"22","author":"JD Finn","year":"2018","unstructured":"Finn, J. D. et al. A single administration of CRISPR\/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227\u20132235 (2018).","journal-title":"Cell Rep."},{"key":"72846_CR63","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nbt1049","volume":"23","author":"M Amendola","year":"2005","unstructured":"Amendola, M., Venneri, M. A., Biffi, A., Vigna, E. & Naldini, L. Coordinate dual-gene transgenesis by lentiviral vectors carrying synthetic bidirectional promoters. Nat. Biotechnol. 23, 108\u2013116 (2005).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR64","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1093\/bioinformatics\/btr167","volume":"27","author":"F Krueger","year":"2011","unstructured":"Krueger, F. & Andrews, S. R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics 27, 1571\u20131572 (2011).","journal-title":"Bioinformatics"},{"key":"72846_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2012-13-10-r87","volume":"13","author":"A Akalin","year":"2012","unstructured":"Akalin, A. et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. 13, R87 (2012).","journal-title":"Genome Biol."},{"key":"72846_CR66","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","volume":"37","author":"K Clement","year":"2019","unstructured":"Clement, K. et al. CRISPResso2 provides accurate and rapid genome editing sequence analysis. Nat. Biotechnol. 37, 224\u2013226 (2019).","journal-title":"Nat. Biotechnol."},{"key":"72846_CR67","doi-asserted-by":"publisher","first-page":"1130736","DOI":"10.3389\/fgeed.2023.1130736","volume":"5","author":"M Rhiel","year":"2023","unstructured":"Rhiel, M. et al. T-CAST: an optimized CAST-Seq pipeline for TALEN confirms superior safety and efficacy of obligate-heterodimeric scaffolds. Front. Genome Ed. 5, 1130736 (2023).","journal-title":"Front. Genome Ed."},{"key":"72846_CR68","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.ymthe.2024.03.006","volume":"32","author":"J Klermund","year":"2024","unstructured":"Klermund, J. et al. On- and off-target effects of paired CRISPR-Cas nickase in primary human cells. Mol. Ther. 32, 1298\u20131310 (2024).","journal-title":"Mol. Ther."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72846-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72846-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72846-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T07:03:24Z","timestamp":1784185404000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-72846-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["72846"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-72846-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.L. is a co-founder, equity holder, and consultant of nChroma Bio, a company developing epigenome editing applications. P.S. was an employee of nChroma Bio at the time the work was conducted and holds an equity interest in the company. A.L., D.C., T.B., A.R., and M.A.C. are inventors on patent applications related to the development of the polyfunctional editing strategy and improved ETR design, filed by IRCCS Ospedale San Raffaele and Fondazione Telethon ETS or by nChroma Bio. All other authors have no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6252"}}